Medicine

Coronavirus, the first vial of vaccine is ready: tests on 45 volunteers are underway

By Giovanni Sapere
2 min read

ShareLinkedInFacebookX

Vial of experimental coronavirus vaccine

The biotech company Moderna has produced the first experimental vaccine against the Coronavirus: tests on 45 volunteers affected by Covid-19 are about to start in Seattle.

Good news in the fight against the Coronavirus. In the midst of the race against time to stem the terrible effects of Covid-19, the American biotech company Moderna has announced it has produced the first vial of mRNA-1273, the first experimental vaccine “for human use”. The American company’s product aims to strengthen the body’s immune defenses by introducing spike proteins into patients’ bodies. These particles are used by the virus to anchor itself to the ACE2 receptor and spread through the body. The researchers explained that spikes function as tiny picks that allow the coronavirus to unhinge the entrance doors of cells in the human respiratory system to penetrate and multiply. Blocking these proteins means disarming the virus: and this is precisely the goal of the experimental vaccine produced by the company Moderna.

Vaccine against the Coronavirus: tests on 45 volunteers are underway

Modern has arrived at the production of the vaccine in a very short time. Only 42 days after the isolation of the Covid-19 genome sequence, the biotech company’s researchers officially presented the first batch of mRNA-1273, the vaccine “for human use”.  The first vials were sent to several American hospitals to begin phase one testing. In Seattle, the vaccine will be injected for the first time in the next few hours to 45 volunteer patients. As the institute explains, participants in the study will receive two injections of the mRNA-1237 vaccine after 28 days and will undergo 11 visits to control any side effects. Different doses of the vaccine will be tested: a first group will receive a dose of 25 micrograms, a second one of 100 and a third one of 250. However, the first reliable results will take a long time. As established by the Food and Drug Administration, the testing phase will last no less than 14 months. It will therefore take at least one year to have a safe and effective vaccine to administer to millions of people.

You may also be interested in —> Coronavirus: a drug for rheumatoid arthritis could stop the virus.

Frequently asked questions

How fast did Moderna produce the vaccine?

Only 42 days after the isolation of the Covid-19 genome sequence, Moderna presented the first batch of mRNA-1273, which it described as the first experimental vaccine for human use.

How will the first test be run?

In Seattle, 45 volunteers will receive two injections 28 days apart and undergo 11 visits to control side effects. Different doses will be tested: 25 micrograms for the first group, 100 for the second and 250 for the third.

How does the vaccine work?

It aims to strengthen the immune defenses by introducing spike proteins into the body. The virus uses these particles to anchor to the ACE2 receptor and spread, so blocking them disarms the virus.

When could the vaccine be available?

The first reliable results will take a long time. The article says the testing phase will last no less than 14 months, so it will take at least one year to have a safe and effective vaccine for millions of people.